Progress toward containment of poliovirus type 2 — Worldwide, 2017

Morbidity and Mortality Weekly Report

Volumn 66, Issue 24, 2017, Pages 649-652

  Previsani, Nicoletta ^a   Singh, Harpal ^a   St Pierre, Jeanette ^b   Boualam, Liliane ^a   Fournier Caruana, Jacqueline ^a   Sutter, Roland W ^a   Zaffran, Michel ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE ERADICATION; GLOBAL HEALTH; HUMAN; POLIOMYELITIS; STATISTICS AND NUMERICAL DATA;

DISEASE ERADICATION; GLOBAL HEALTH; HUMANS; POLIOMYELITIS;

EID: 85021398863     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: 10.15585/mmwr.mm6624a5     Document Type: Note

References (10)

1. Diop OM, Asghar H, Gavrilin E, et al. Virologic monitoring of poliovirus type 2 after oral poliovirus vaccine type 2 withdrawal in April 2016— worldwide, 2016-2017. MMWR Morb Mortal Wkly Rep 2017;66:538-42. https://doi.org/10.15585/mmwr.mm6620a4
2. Previsani N, Tangermann RH, Tallis G, Jafari HS. World Health Organization guidelines for containment of poliovirus following type-specific polio eradication—worldwide, 2015. MMWR Morb Mortal Wkly Rep 2015;64:913-7. https://doi.org/10.15585/mmwr.mm6433a5
3. Global Polio Eradication Initiative. Polio eradication and endgame strategic plan 2013-2018. Geneva, Switzerland: World Health Organization; 2013. http://polioeradication.org/who-we-are/strategy/
4. Morales M, Tangermann RH, Wassilak SG. Progress toward polio eradication—worldwide, 2015-2016. MMWR Morb Mortal Wkly Rep 2016;65:470-3. https://doi.org/10.15585/mmwr.mm6518a4
5. Nnadi C, Damisa E, Esapa L, et al. Continued endemic wild poliovirus transmission in security-compromised areas—Nigeria, 2016. MMWR Morb Mortal Wkly Rep 2017;66:190-3. https://doi.org/10.15585/mmwr.mm6607a2
6. World Health Organization. Meeting of the Strategic Advisory Group of Experts on immunization, October 2016—conclusions and recommendations. Wkly Epidemiol Rec 2016;91:561-82.
7. World Health Organization. WHO Global Action Plan to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of oral polio vaccine use—GAPIII. Geneva, Switzerland: World Health Organization; 2015. http://www.polioeradication.org/wp-content/uploads/2016/12/GAPIII_2014.pdf
8. World Health Organization. Containment certification scheme to support the WHO Global Action Plan for Poliovirus Containment (GAPIII-CCS). Geneva, Switzerland: World Health Organization; 2017.
9. Global Commission for the Certification of Poliomyelitis Eradication. Summary of findings, decisions and recommendations. Presented at the 14th Meeting of the Global Commission for the Certification of Poliomyelitis Eradication, Bali, Indonesia; September 20-21, 2015.
10. European Center for Disease Control. Poliomyelitis-facility-related infection with WPV2—Netherlands. Communicable disease threats report. Week 16, April 16-22, 2017. Solna, Sweden: European Center for Disease Control; 2017. http://ecdc.europa.eu/en/publications/Publications/Communicable-disease-threats-report-22-apr-2017.pdf